Literature DB >> 7624335

Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription.

M W Russo1, B R Sevetson, J Milbrandt.   

Abstract

NGFI-A (also called Egr1, Zif268, or Krox24) and the closely related proteins Krox20, NGFI-C, and Egr3 are zinc-finger transcription factors encoded by immediate-early genes which are induced by a wide variety of extracellular stimuli. NGFI-A has been implicated in cell proliferation, macrophage differentiation, synaptic activation, and long-term potentiation, whereas Krox20 is critical for proper hindbrain segmentation and peripheral nerve myelination. In previous work, a structure/function analysis of NGFI-A revealed a 34-aa inhibitory domain that was hypothesized to be the target of a cellular factor that represses NGFI-A transcriptional activity. Using the yeast two-hybrid system, we have isolated a cDNA clone which encodes a protein that interacts with this inhibitory domain and inhibits the ability of NGFI-A to activate transcription. This NGFI-A-binding protein, NAB1, is a 570-aa nuclear protein that bears no obvious sequence homology to known proteins. NAB1 also represses Krox20 activity, but it does not influence Egr3 or NGFI-G, thus providing a mechanism for the differential regulation of this family of immediate-early transcription factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624335      PMCID: PMC41432          DOI: 10.1073/pnas.92.15.6873

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A.

Authors:  N P Pavletich; C O Pabo
Journal:  Science       Date:  1991-05-10       Impact factor: 47.728

3.  The serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional activator.

Authors:  P Lemaire; C Vesque; J Schmitt; H Stunnenberg; R Frank; P Charnay
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

4.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

5.  Construction of an improved host strain for two hybrid screening.

Authors:  H E Feilotter; G J Hannon; C J Ruddell; D Beach
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

Review 6.  Cell cycle targets of the DNA tumor viruses.

Authors:  J R Nevins
Journal:  Curr Opin Genet Dev       Date:  1994-02       Impact factor: 5.578

Review 7.  Cytomegalovirus plasmid vectors for permanent lines of polarized epithelial cells.

Authors:  C B Brewer
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

8.  Transcriptional repression directed by the yeast alpha 2 protein in vitro.

Authors:  B M Herschbach; M B Arnaud; A D Johnson
Journal:  Nature       Date:  1994-07-28       Impact factor: 49.962

9.  Promoter region of the human platelet-derived growth factor A-chain gene.

Authors:  Y Takimoto; Z Y Wang; K Kobler; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

10.  The immediate-early gene Egr-1 regulates the activity of the thymidine kinase promoter at the G0-to-G1 transition of the cell cycle.

Authors:  G Molnar; A Crozat; A B Pardee
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 5.069

View more
  87 in total

1.  NAB2: a transcriptional brake for activated gene expression in the vessel wall?

Authors:  J M Miano; B C Berk
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  Blockade of NGF-induced neurite outgrowth by a dominant-negative inhibitor of the egr family of transcription regulatory factors.

Authors:  Y Levkovitz; K J O'Donovan; J M Baraban
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

Review 3.  Pathways of Egr-1-mediated gene transcription in vascular biology.

Authors:  E S Silverman; T Collins
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

4.  Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily.

Authors:  U Dressel; D Thormeyer; B Altincicek; A Paululat; M Eggert; S Schneider; S P Tenbaum; R Renkawitz; A Baniahmad
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  Post-transcriptional regulation of zenk expression associated with zebra finch vocal development.

Authors:  O Whitney; K Soderstrom; F Johnson
Journal:  Brain Res Mol Brain Res       Date:  2000-09-15

Review 6.  Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.

Authors:  L M Khachigian
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 7.  Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy.

Authors:  Swati Bhattacharyya; Minghua Wu; Feng Fang; Warren Tourtellotte; Carol Feghali-Bostwick; John Varga
Journal:  Matrix Biol       Date:  2011-04-13       Impact factor: 11.583

Review 8.  Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis.

Authors:  Florian Blaschke; Dennis Bruemmer; Ronald E Law
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

9.  The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination.

Authors:  Holly Hung; Rebecca Kohnken; John Svaren
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

10.  EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin.

Authors:  Joerg Kumbrink; Kathrin H Kirsch; Judith P Johnson
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.